Navigation Links
Hyperviscous fluids: Better treatment for severe blood loss
Date:4/28/2008

lost on the battlefield would be good because it lowered blood viscosity, making it easier for the heart to pump.

Intaglietta said that while more research is needed, Our findings and others suggest that the ATLS guidelines need to be modified.

Studies such as Intagliettas are important because it uses not only hypertonic saline, said Coimbra, but also other adjuncts which may increase the effects of hypertonic saline in treating those patients and in advancing our knowledge about shock resuscitation.


'/>"/>

Contact: Rex Graham
ragraham@ucsd.edu
858-822-3075
University of California - San Diego
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors
2. How and where fat is stored predicts disease risk better than weight
3. Continuous oral contraceptives better at easing pain, bleeding
4. David H. Ledbetter, PhD, FACMG is the 2008-2009 Luminex/ACMGF Award recipient
5. Ant guts could pave the way for better drugs
6. Newly defined signaling pathway could mean better biofuel sources
7. Analysis calls for medical device information to better serve patients and doctors
8. Better protection for biomedial devices could result from Rutgers-Camden research
9. Researchers develop better membranes for water treatment, drug delivery
10. Marine scientists warn human safety, prosperity depend on better ocean observing system
11. Human safety, prosperity depend on better ocean observing system: Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hyperviscous fluids: Better treatment for severe blood loss
(Date:2/5/2015)... , January 28, 2015 ... Analysis, Size And Segment Forecasts To 2020 has Been ... IR camera market is expected to reach USD 5.10 ... Grand View Research, Inc. IR cameras help identify the ... are expected to witness surging demand in medical imaging ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying ... power and potential for genomic science as a means ... disease prevention and treatment.  I was honored to participate ... government-funded precision medicine program. Since the ... science of genomics—from the first sequenced genome of a ...
(Date:1/22/2015)... 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is ... the State of Washington,s Department of ... enrollment and central issuance system for driver,s licenses and identification ... project planning and development will start in January 2015, with ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Valid USA Signs Contract For Washington Driver's License Issuance 2
... 9, 2009 -- Researchers at the Burnham Institute ... algorithms used in digital communications can help scientists ... Giovanni Paternostro, M.D., Ph.D., was published in the ... Biology . Using the stack sequential algorithm, ...
... unveil a novel "two-stage, approach for developing new energy ... emissions and create a cleaner economy during a policy ... York Ave. N.W. in Washington, D.C. , ... Mellon, the University of Minnesota, The Vermont Law School ...
... As children transition from preschool-age to school-age, they ... not meet current recommendations and may contribute to childhood ... issue of the Journal of Nutrition Education and ... pre-school children (2 to 5 years) had relatively good ...
Cached Biology News:Digital communication technology helps clear path to personalized therapies 2Carnegie Mellon to unveil new sequestration plan 2Eating habits and exercise behaviors in children can deteriorate early 2
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... its newly developed Bruton,s tyrosine kinase (BTK) inhibitor ... The results of these preclinical evaluations have been ... The feedback received from the Agency is supportive ... Additional preclinical work is required to begin a ...
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... Md. (PRWEB) February 27, 2015 ... Chromatography system (Nexera UC) can sequentially analyze up ... separation combined with high-sensitivity detection of targets by ... is designed to fulfill the measurement requirements of ... in food products, drug delivery and search for ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Global Market Report of Trypsin 2014-2018 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3
... DIEGO, Nov. 5, 2010 Halozyme Therapeutics, Inc. ... developing and commercializing products targeting the extracellular ... drug delivery markets, today reported financial results for ... (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ) ...
... the first in a series of video programs called ... Miles O,Brien and currently airing nationally on the the ... at what happens when genius meets possibility: stories about ... world. The 26-part video series is produced by ...
... 2010 Cannabis Science, Inc. (OTC Bulletin Board: ... pharmaceutical cannabis products announced today that regardless of the ... electoral issues throughout the country, it is apparent that ... more important than ever, as the demand for the ...
Cached Biology Technology:Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 2Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 3Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 4Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 5Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 6Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 7Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 2Proposition 19 Decision Prompts Cannabis Science to Anticipate Increased Demand for its Pharmaceutical Products for Critical Ailments and Begin the Formal Application Process for FDA Clinical Trials Immediately 3
Peptide-affinity Purified Polyclonal Antibody to Purinergic Receptor P2Y12...
Polyclonal Antibody to CLAN...
Request Info...
IRF7 Immunogen: Synthetic peptide corresponding to residues E(463) G T Q R E G V S S L D S S S(477) of human IRF7. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: